{
    "hands_on_practices": [
        {
            "introduction": "The clinical significance of any structural chromosome abnormality ultimately boils down to gene dosage. This foundational exercise challenges you to reason from first principles about the phenotypic consequences of gaining versus losing genetic material. By comparing a deletion with its reciprocal duplication, you will apply the critical concepts of haploinsufficiency and triplosensitivity to predict which scenario is likely to be more severe, a type of reasoning essential in clinical genetics .",
            "id": "5084199",
            "problem": "A clinical genetics team identifies in one patient a heterozygous interstitial deletion of size $5$ Mb on an autosome. High-resolution sequencing shows that the deleted interval encompasses $5$ genes that have documented haploinsufficiency, meaning that one functional allele is not sufficient to maintain normal phenotype. A second patient carries a heterozygous duplication of the same $5$ Mb interval, with the same $5$ genes increased in copy number. Both variants arose as recurrent Copy Number Variations (CNVs), consistent with formation by Non-Allelic Homologous Recombination (NAHR) between flanking low-copy repeats. The clinical team asks you to reason, from first principles of gene dosage and meiotic behavior of structural variants, which scenario is expected to produce greater phenotypic severity and why. Assume no prior evidence that these $5$ genes are triplosensitive, and that background deleterious variants in the population are rare but nonzero. Which option best constructs the rationale?\n\nA. The deletion is expected to be more severe because it reduces gene copy number from $2$ to $1$ for $5$ haploinsufficient genes, likely dropping below functional dosage thresholds; it can also unmask recessive pathogenic variants on the remaining allele and remove cis-regulatory elements within the $5$ Mb region. By contrast, the duplication raises gene copy number from $2$ to $3$, which is frequently tolerated unless the genes are triplosensitive, and the meiotic pairing consequences of such CNVs do not, by themselves, increase clinical severity in the heterozygous carrier.\n\nB. The duplication is expected to be more severe because increasing dosage universally creates dominant-negative effects across all $5$ genes, whereas a deletion is buffered by homeostatic upregulation that restores expression to $100\\%$.\n\nC. The deletion and duplication should have equivalent severity because changing dosage by $\\pm 1$ copy produces symmetric, linear changes in pathway outputs around the wild-type state, making loss and gain of one copy equally disruptive.\n\nD. The duplication is expected to be more severe because, in duplication heterozygotes, meiotic recombination frequently produces dicentric bridges and widespread somatic aneuploidy, whereas deletions do not.\n\nE. The deletion is expected to be less severe because haploinsufficient genes, by definition, tolerate $50\\%$ dosage, while duplications more often disrupt Topologically Associating Domains (TADs), causing enhancer hijacking and stronger misexpression than deletions.",
            "solution": "### Step 1: Extract Givens\n\nThe problem statement provides the following information:\n- A heterozygous interstitial deletion of size $5$ Mb on an autosome is identified in one patient.\n- The deleted interval contains $5$ genes.\n- These $5$ genes have documented haploinsufficiency.\n- Haploinsufficiency is defined as the state where one functional allele is not sufficient to maintain a normal phenotype.\n- A second patient carries a heterozygous duplication of the same $5$ Mb interval.\n- The same $5$ genes are increased in copy number in the second patient.\n- Both variants are recurrent Copy Number Variations (CNVs) formed by Non-Allelic Homologous Recombination (NAHR).\n- Assumption 1: There is no prior evidence that these $5$ genes are triplosensitive.\n- Assumption 2: Background deleterious variants in the population are rare but nonzero.\n- The question asks to compare the expected phenotypic severity of the deletion versus the duplication based on first principles of gene dosage and meiotic behavior.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem statement is evaluated based on the established criteria.\n\n- **Scientifically Grounded:** The problem is based on core principles of medical genetics, including gene dosage, haploinsufficiency, triplosensitivity, copy number variation (CNV), and meiotic segregation of structural variants. These are well-established and fundamental concepts.\n- **Well-Posed:** The question asks for a reasoned comparison of two scenarios based on a defined set of facts and assumptions. It is structured to allow for a unique and logical conclusion derived from these premises.\n- **Objective:** The language is technical, precise, and free of subjective or ambiguous terminology. The definition of haploinsufficiency is explicitly provided, and key assumptions (e.g., lack of known triplosensitivity) are clearly stated.\n- **Completeness and Consistency:** The problem is self-contained. It provides all necessary information to formulate a reasoned argument. The data are consistent; a $5$ Mb CNV affecting multiple genes is a clinically realistic scenario.\n- **Realism:** The scenario of a recurrent $5$ Mb deletion/duplication syndrome mediated by NAHR is highly realistic and representative of many known genomic disorders (e.g., DiGeorge/22q11.2 deletion syndrome and its reciprocal duplication).\n\n### Step 3: Verdict and Action\n\nThe problem statement is valid. It is a well-formulated question in medical genetics that can be answered by applying first principles. I will now proceed with the derivation of the solution and evaluation of the options.\n\n### Derivation from First Principles\n\nThe core of the problem is to compare the phenotypic consequences of reducing the copy number of $5$ genes from two to one (deletion) versus increasing it from two to three (duplication).\n\n1.  **Consequences of the Deletion:**\n    A heterozygous deletion results in a gene copy number of $1$ for the affected genes. The dosage of the gene products is expected to be approximately $50\\%$ of the normal diploid level. The problem explicitly states that these $5$ genes are **haploinsufficient**. By definition, this means that a $50\\%$ dosage is insufficient for a normal phenotype. Therefore, the deletion is expected to be pathogenic due to the functional consequences of under-expression for all $5$ of these genes.\n    A second principle is the potential for **unmasking recessive alleles**. The patient is heterozygous for the deletion, meaning they have a normal homologous chromosome. This chromosome may carry rare, recessive, loss-of-function variants within the region corresponding to the deletion. In a diploid state, such a recessive allele would be masked by the functional allele on the other chromosome. However, when the corresponding allele is deleted, the recessive variant is unmasked and will be expressed, potentially adding to the phenotypic severity. The problem correctly notes that such variants are \"rare but nonzero,\" making this a plausible contributing mechanism.\n    A third mechanism is the disruption of the **cis-regulatory landscape**. A large $5$ Mb deletion can remove enhancers, silencers, or insulators, leading to dysregulation of genes located near, but outside of, the deleted segment.\n\n2.  **Consequences of the Duplication:**\n    A heterozygous duplication results in a gene copy number of $3$ for the affected genes. The dosage of the gene products is expected to be approximately $150\\%$ of the normal diploid level. Pathogenicity from increased dosage is termed **triplosensitivity**. The problem explicitly states there is \"no prior evidence that these $5$ genes are triplosensitive.\" While a gene dosage increase can be detrimental, it is not guaranteed to be pathogenic. Many genes tolerate a $150\\%$ expression level without a significant phenotypic effect. In the absence of evidence for triplosensitivity, we cannot assume the same degree of pathogenicity as we can for the deletion of known haploinsufficient genes. Empirically, for many recurrent CNVs, the deletion phenotype is more severe than the reciprocal duplication phenotype, although this is not a universal rule.\n\n3.  **Meiotic Consequences:**\n    During meiosis I, both heterozygous deletions and duplications can lead to mispairing of homologous chromosomes, forming a structural loop. Crossing over within such a loop can produce unbalanced gametes (e.g., with further duplications/deletions, or acentric/dicentric chromosomes). However, these events determine the genetic risk for the **offspring** of the carrier. They do not, in themselves, determine the clinical severity of the somatic phenotype *in the carrier patient*. Therefore, meiotic behavior is relevant for genetic counseling but is not a primary determinant of the patient's own severity.\n\n**Conclusion:** The deletion is predicted to be more severe. The pathogenicity is near-certain due to the known haploinsufficiency of $5$ genes. This is a direct violation of dosage requirements. The duplication's pathogenicity is contingent on triplosensitivity, which is unknown and generally considered less common than haploinsufficiency. Furthermore, the deletion carries the additional risk of unmasking recessive alleles, a mechanism not applicable to the duplication.\n\n### Option-by-Option Analysis\n\n**A. The deletion is expected to be more severe because it reduces gene copy number from $2$ to $1$ for $5$ haploinsufficient genes, likely dropping below functional dosage thresholds; it can also unmask recessive pathogenic variants on the remaining allele and remove cis-regulatory elements within the $5$ Mb region. By contrast, the duplication raises gene copy number from $2$ to $3$, which is frequently tolerated unless the genes are triplosensitive, and the meiotic pairing consequences of such CNVs do not, by themselves, increase clinical severity in the heterozygous carrier.**\nThis option provides a comprehensive and accurate rationale. It correctly identifies haploinsufficiency as the primary driver of severity for the deletion. It includes the valid secondary mechanism of unmasking recessive variants and the plausible removal of cis-regulatory elements. It correctly frames the effect of the duplication as being conditional on triplosensitivity (which is not known) and notes that increased dosage is often tolerated. Finally, it correctly states that meiotic consequences do not determine the carrier's own severity.\n**Verdict: Correct**\n\n**B. The duplication is expected to be more severe because increasing dosage universally creates dominant-negative effects across all $5$ genes, whereas a deletion is buffered by homeostatic upregulation that restores expression to $100\\%$.**\nThis option is fundamentally flawed. An increase in dosage of a wild-type gene does not \"universally\" create a dominant-negative effect; this is a specific mechanism of action for certain types of mutant alleles. More importantly, the claim that a deletion of a haploinsufficient gene is \"buffered by homeostatic upregulation that restores expression to $100\\%$\" is a direct contradiction of the definition of haploinsufficiency. If upregulation could fully compensate, the gene would not be haploinsufficient.\n**Verdict: Incorrect**\n\n**C. The deletion and duplication should have equivalent severity because changing dosage by $\\pm 1$ copy produces symmetric, linear changes in pathway outputs around the wild-type state, making loss and gain of one copy equally disruptive.**\nThis option posits a simplistic and generally false \"gene balance\" model. Biological systems rarely respond symmetrically to under- and over-expression. The problem provides specific information—known haploinsufficiency without known triplosensitivity—that explicitly breaks this assumed symmetry. The argument must be based on the given biological properties, not a generalized physical analogy.\n**Verdict: Incorrect**\n\n**D. The duplication is expected to be more severe because, in duplication heterozygotes, meiotic recombination frequently produces dicentric bridges and widespread somatic aneuploidy, whereas deletions do not.**\nThis option incorrectly conflates germline and somatic events. Meiotic recombination and its consequences (like dicentric bridges) affect the genetic constitution of gametes, not the somatic cells of the patient. The term \"widespread somatic aneuploidy\" is inaccurate in this context. While meiotic instability is a feature of such carriers, it does not cause the clinical phenotype in the carrier themselves via this mechanism.\n**Verdict: Incorrect**\n\n**E. The deletion is expected to be less severe because haploinsufficient genes, by definition, tolerate $50\\%$ dosage, while duplications more often disrupt Topologically Associating Domains (TADs), causing enhancer hijacking and stronger misexpression than deletions.**\nThis option begins with a statement that is the exact opposite of the truth. Haploinsufficient genes, by definition, **do not** tolerate $50\\%$ dosage; this dosage level causes a pathological phenotype. This fatal error makes the entire option invalid. The second clause, which makes a strong claim about duplications being worse for TAD disruption, is a speculative generalization, but the first clause is a direct contradiction of a provided definition.\n**Verdict: Incorrect**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Understanding how structural variants lead to unbalanced gametes requires a firm grasp of their behavior during meiosis. This practice provides a bridge from theoretical segregation patterns to real-world empirical data. You will analyze the results of a sperm Fluorescence In Situ Hybridization (FISH) study on a reciprocal translocation carrier to deduce the relative frequencies of alternate and adjacent segregation, demonstrating how laboratory techniques can quantify meiotic events .",
            "id": "5084181",
            "problem": "A man is heterozygous for a reciprocal translocation between two autosomes, described cytogenetically as $t(4;11)(q21;q23)$. During meiosis I, the four homologous chromosome arms pair to form a quadrivalent, which can resolve by alternate segregation (yielding balanced gametes) or by adjacent-1 segregation (yielding duplication/deficiency of the translocated segments and therefore unbalanced gametes). Adjacent-2 segregation (homologous centromeres to the same pole) is empirically rare, and $3:1$ segregation produces hyperhaploid nuclei that are excluded by the laboratory’s gating. A Fluorescence in situ hybridization (FISH) assay was conducted on ejaculated sperm using locus-specific probes to the distal $4q$ and distal $11q$ segments and centromeric probes to $4$ and $11$, scoring only haploid nuclei. Among $n = 2000$ sperm nuclei, $800$ were unbalanced by FISH ($40\\%$), and among the entire set, the signature consistent with adjacent-2 was observed in $n = 20$ nuclei ($1\\%$). Assume that the assay detects unbalanced products of adjacent-1 and adjacent-2 with high sensitivity and that $3:1$ products are excluded by DNA-content gating.\n\nBased solely on the core definitions of meiotic segregation in reciprocal translocations and the observations above, which statement best describes the likely segregation bias between alternate and adjacent-1 in this translocation case?\n\nA. The data indicate a strong preference for alternate segregation, with $f_{\\text{alt}} \\ge 80\\%$ and $f_{\\text{adj1}} \\le 20\\%$.\n\nB. The data indicate a moderate preference for alternate segregation, with $f_{\\text{alt}} \\approx 60\\%$ and $f_{\\text{adj1}} \\approx 39\\%$ to $40\\%$, after accounting for a small adjacent-2 component.\n\nC. The data indicate no orientation bias, with $f_{\\text{alt}} \\approx f_{\\text{adj1}} \\approx 50\\%$, because unbalanced products predominantly arise from $3:1$ events.\n\nD. The data indicate a preference for adjacent-1 segregation, with $f_{\\text{adj1}} \\ge 60\\%$, because the unbalanced fraction is $40\\%$.",
            "solution": "The problem is scientifically grounded, well-posed, objective, and contains sufficient information for a unique solution. The described genetic scenario, experimental setup (FISH on sperm), and segregation patterns are standard in human cytogenetics. The data provided are consistent and plausible. Thus, the problem is valid.\n\nThe core of the problem is to deduce the frequencies of alternate ($f_{\\text{alt}}$) and adjacent-1 ($f_{\\text{adj1}}$) segregation from the provided sperm FISH data. The total population of scored nuclei ($n = 2000$) represents the sum of gametes that result from the three types of $2:2$ segregation, as $3:1$ segregation products are explicitly excluded.\n\nThe total segregation events within the scored sample can be expressed as:\n$$\nf_{\\text{total}} = f_{\\text{alt}} + f_{\\text{adj1}} + f_{\\text{adj2}} = 100\\%\n$$\nwhere $f_{\\text{alt}}$, $f_{\\text{adj1}}$, and $f_{\\text{adj2}}$ are the frequencies of alternate, adjacent-1, and adjacent-2 segregation, respectively.\n\n1.  **Alternate segregation** is the only mode that produces chromosomally balanced gametes (either normal or carrying the balanced translocation). Therefore, the frequency of balanced gametes is equal to the frequency of alternate segregation.\n2.  **Adjacent-1 and adjacent-2 segregation** both produce chromosomally unbalanced gametes. The total frequency of unbalanced gametes is the sum of the frequencies of these two modes.\n\nFrom the problem statement, we are given the following data:\n- Total number of scored nuclei: $n = 2000$.\n- Number of unbalanced nuclei: $800$. The frequency of unbalanced gametes is therefore:\n$$\nf_{\\text{unbalanced}} = \\frac{800}{2000} = 0.40 = 40\\%\n$$\n- Number of nuclei with the signature of adjacent-2 segregation: $20$. The frequency of adjacent-2 segregation is:\n$$\nf_{\\text{adj2}} = \\frac{20}{2000} = 0.01 = 1\\%\n$$\n\nUsing these values, we can calculate the frequencies of the other segregation patterns.\n\nThe frequency of balanced gametes must be the complement of the unbalanced fraction:\n$$\nf_{\\text{balanced}} = 100\\% - f_{\\text{unbalanced}} = 100\\% - 40\\% = 60\\%\n$$\nSince only alternate segregation yields balanced products, the frequency of alternate segregation is:\n$$\nf_{\\text{alt}} = f_{\\text{balanced}} = 60\\%\n$$\n\nThe total frequency of unbalanced gametes is the sum of adjacent-1 and adjacent-2 frequencies:\n$$\nf_{\\text{unbalanced}} = f_{\\text{adj1}} + f_{\\text{adj2}}\n$$\nWe can now solve for the frequency of adjacent-1 segregation:\n$$\nf_{\\text{adj1}} = f_{\\text{unbalanced}} - f_{\\text{adj2}} = 40\\% - 1\\% = 39\\%\n$$\nSo, our calculated frequencies are $f_{\\text{alt}} = 60\\%$, $f_{\\text{adj1}} = 39\\%$, and $f_{\\text{adj2}} = 1\\%$. These sum to $100\\%$. The data show a segregation pattern where alternate segregation ($60\\%$) is more common than adjacent-1 segregation ($39\\%$), indicating a moderate bias towards the production of balanced gametes.\n\nNow, we evaluate each option:\n\n**A. The data indicate a strong preference for alternate segregation, with $f_{\\text{alt}} \\ge 80\\%$ and $f_{\\text{adj1}} \\le 20\\%$.**\nOur calculation shows $f_{\\text{alt}} = 60\\%$, which does not satisfy $f_{\\text{alt}} \\ge 80\\%$. Our calculation shows $f_{\\text{adj1}} = 39\\%$, which does not satisfy $f_{\\text{adj1}} \\le 20\\%$.\nVerdict: **Incorrect**.\n\n**B. The data indicate a moderate preference for alternate segregation, with $f_{\\text{alt}} \\approx 60\\%$ and $f_{\\text{adj1}} \\approx 39\\%$ to $40\\%$, after accounting for a small adjacent-2 component.**\nOur calculation yields $f_{\\text{alt}} = 60\\%$, which perfectly matches the approximation. Our calculation yields $f_{\\text{adj1}} = 39\\%$, which falls within the stated range of $39\\%$ to $40\\%$. The phrase \"after accounting for a small adjacent-2 component\" correctly describes the reasoning needed to distinguish $f_{\\text{adj1}}$ from the total $f_{\\text{unbalanced}}$. The qualitative description \"moderate preference for alternate segregation\" is appropriate for a $60\\%$ versus $39\\%$ split.\nVerdict: **Correct**.\n\n**C. The data indicate no orientation bias, with $f_{\\text{alt}} \\approx f_{\\text{adj1}} \\approx 50\\%$, because unbalanced products predominantly arise from $3:1$ events.**\nOur calculations show $f_{\\text{alt}} = 60\\%$ and $f_{\\text{adj1}} = 39\\%$, which are not approximately $50\\%$. The statement also contains a factual error based on the problem's own constraints: it claims $3:1$ events are the predominant source of unbalanced products, but the problem explicitly states these are excluded from the analysis by gating.\nVerdict: **Incorrect**.\n\n**D. The data indicate a preference for adjacent-1 segregation, with $f_{\\text{adj1}} \\ge 60\\%$, because the unbalanced fraction is $40\\%$.**\nThis statement claims a preference for adjacent-1 segregation. Our results show $f_{\\text{alt}} = 60\\%$ and $f_{\\text{adj1}} = 39\\%$, so the preference is for alternate segregation, not adjacent-1. The numerical claim $f_{\\text{adj1}} \\ge 60\\%$ is also false. The reasoning provided is illogical; an unbalanced fraction of $40\\%$ implies a balanced fraction of $60\\%$, which directly contradicts a preference for any type of unbalanced segregation.\nVerdict: **Incorrect**.",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "A primary role of a medical geneticist is to translate complex cytogenetic information into practical recurrence risks for families. This final practice places you in a realistic genetic counseling scenario involving a common Robertsonian translocation. To solve it, you must integrate your knowledge of meiotic segregation, embryonic viability, and maternal age-related background risks to calculate the probability of specific clinical outcomes in an offspring, a key skill for reproductive counseling .",
            "id": "5084189",
            "problem": "A phenotypically normal woman is heterozygous for a Robertsonian translocation between chromosomes $13$ and $14$, denoted $r(13;14)$. She plans a pregnancy with a karyotypically normal partner. Assume the following foundational facts and model assumptions:\n\n- In meiosis I, the homologous centromeres for the acrocentric chromosomes $13$ and $14$ and the derivative chromosome $der(13;14)$ form a trivalent. A trivalent can orient in three ways at anaphase I, each with equal probability under random orientation, sending either $\\{der(13;14)+13\\}$ versus $\\{14\\}$, or $\\{der(13;14)+14\\}$ versus $\\{13\\}$, or $\\{13+14\\}$ versus $\\{der(13;14)\\}$ to opposite poles.\n- Each of these three orientations yields two reciprocal gamete types with equal frequency, so each of the six possible gamete types has probability $1/6$.\n- After fertilization by a normal gamete, only the following conceptuses are viable to live birth with nonzero probability: normal disomy for both $13$ and $14$, balanced $r(13;14)$ carriers, and trisomy $13$ (Patau syndrome). Conceptuses with monosomy $13$, trisomy $14$, or monosomy $14$ do not survive to live birth.\n- Let $s_{13}$ denote the fraction of trisomy $13$ conceptions that survive to live birth. Use $s_{13} = 0.020$.\n- Let $b_{21}$ denote the maternal age-adjusted background risk (at live birth) for free trisomy $21$ (Down syndrome) due to meiotic nondisjunction, independent of the translocation. Use $b_{21} = 5.8 \\times 10^{-3}$ (appropriate for maternal age $36$).\n- For “Robertsonian Down syndrome” (translocation Down syndrome caused by $r(14;21)$ or $r(21;21)$), assume the risk contributed by $r(13;14)$ segregation is $0$ (ignore extremely rare de novo Robertsonian events involving chromosome $21$).\n\nUsing only the core definitions of meiotic trivalent formation, random orientation, and the viability categories above, derive from first principles the probability at live birth for each of the following outcomes in the offspring of this $r(13;14)$ carrier: trisomy $21$, trisomy $13$, and Robertsonian Down syndrome. Express your three final risks as decimal fractions. Round your three answers to four significant figures.",
            "solution": "### Validation\nThe problem is scientifically grounded, well-posed, objective, and contains sufficient information for a unique solution. The described genetic scenario, meiotic model, and numerical values are standard and realistic for the context of genetic counseling. The problem is valid.\n\n### Solution Derivation\nThe objective is to calculate the probabilities at live birth for three distinct outcomes: trisomy $21$, trisomy $13$, and Robertsonian Down syndrome.\n\nFirst, we analyze the genetic content of the six possible gamete types produced by the female carrier, according to the specified meiotic model. Each gamete type has a probability of formation of $P_{\\text{gamete}} = 1/6$. The partner produces normal gametes containing one chromosome $13$ and one chromosome $14$.\n\nThe six possible maternal gametes and their corresponding zygotes after fertilization are:\n1.  **Gamete type 1**: $\\{13, 14\\}$ (Normal). Fertilization by a normal $\\{13, 14\\}$ sperm yields a $\\{13, 13, 14, 14\\}$ zygote. This is a karyotypically normal conceptus. It is viable to term.\n2.  **Gamete type 2**: $\\{der(13;14)\\}$ (Balanced). Fertilization yields a $\\{13, 14, der(13;14)\\}$ zygote. This is a phenotypically normal, balanced translocation carrier. It is viable to term.\n3.  **Gamete type 3**: $\\{der(13;14), 13\\}$ (Unbalanced). Fertilization yields a $\\{13, 13, 14, der(13;14)\\}$ zygote. This conceptus has three copies of the long arm of chromosome $13$ and is classified as Trisomy $13$ (Patau syndrome). This is viable to live birth with a specific probability.\n4.  **Gamete type 4**: $\\{14\\}$ (Unbalanced). Fertilization yields a $\\{13, 14, 14\\}$ zygote. This conceptus has only one copy of chromosome $13$ and is classified as Monosomy $13$. It is not viable to live birth.\n5.  **Gamete type 5**: $\\{der(13;14), 14\\}$ (Unbalanced). Fertilization yields a $\\{13, 14, 14, der(13;14)\\}$ zygote. This conceptus has three copies of the long arm of chromosome $14$ and is classified as Trisomy $14$. It is not viable to live birth.\n6.  **Gamete type 6**: $\\{13\\}$ (Unbalanced). Fertilization yields a $\\{13, 13, 14\\}$ zygote. This conceptus has only one copy of chromosome $14$ and is classified as Monosomy $14$. It is not viable to live birth.\n\nThe calculation of risk is a conditional probability, conditioned on a live birth occurring. We must first determine the total probability of a live birth by summing the probabilities of all outcomes that can survive to term.\n\nLet $P(C_i)$ be the probability of conceiving a zygote of type $i \\in \\{1, 2, \\dots, 6\\}$, so $P(C_i) = 1/6$.\nLet $P(L|C_i)$ be the probability of a live birth given conception of type $i$.\n- $P(L|C_1) = 1$\n- $P(L|C_2) = 1$\n- $P(L|C_3) = s_{13} = 0.020$\n- $P(L|C_4) = 0$\n- $P(L|C_5) = 0$\n- $P(L|C_6) = 0$\n\nThe total probability of a live birth, $P(L)$, is the sum of the probabilities of all conception-to-live-birth pathways:\n$$P(L) = \\sum_{i=1}^{6} P(L|C_i)P(C_i)$$\n$$P(L) = (1 \\times \\frac{1}{6}) + (1 \\times \\frac{1}{6}) + (s_{13} \\times \\frac{1}{6}) + (0 \\times \\frac{1}{6}) + (0 \\times \\frac{1}{6}) + (0 \\times \\frac{1}{6})$$\n$$P(L) = \\frac{1}{6} + \\frac{1}{6} + \\frac{s_{13}}{6} = \\frac{2 + s_{13}}{6}$$\nThis is the total probability of a live birth per conception, considering only the consequences of the translocation. This term will serve as the normalization factor for translocation-related risks.\n\n**1. Probability of Trisomy 13 at Live Birth ($P(T_{13}|L)$)**\nThis is the probability of a trisomy $13$ conceptus that survives to term, divided by the total probability of any live birth.\nThe probability of conceiving a trisomy $13$ zygote and it resulting in a live birth is $P(L \\cap C_3) = P(L|C_3)P(C_3) = s_{13} \\times (1/6)$.\n$$P(T_{13}|L) = \\frac{P(L \\cap C_3)}{P(L)} = \\frac{s_{13}/6}{(2+s_{13})/6} = \\frac{s_{13}}{2+s_{13}}$$\nSubstituting the given value $s_{13} = 0.020$:\n$$P(T_{13}|L) = \\frac{0.020}{2 + 0.020} = \\frac{0.020}{2.020} \\approx 0.00990099...$$\nRounded to four significant figures, the probability is $0.009901$.\n\n**2. Probability of Trisomy 21 at Live Birth ($P(T_{21}|L)$)**\nThe problem states that the background risk for free trisomy $21$ (Down syndrome) at live birth is $b_{21} = 5.8 \\times 10^{-3}$, and that this risk is *independent* of the translocation. In the context of genetic counseling, independent risks are considered separately. The translocation affects the viability of pregnancies involving chromosomes $13$ and $14$, but it does not alter the fundamental, age-related probability of a nondisjunction event for chromosome $21$ leading to a live birth. Therefore, the risk for trisomy $21$ in this pregnancy is the maternal age-adjusted background risk.\n$$P(T_{21}|L) = b_{21} = 5.8 \\times 10^{-3} = 0.0058$$\nExpressed to four significant figures, the probability is $0.005800$.\n\n**3. Probability of Robertsonian Down Syndrome at Live Birth ($P(RDS|L)$)**\nRobertsonian Down syndrome is caused by a translocation involving chromosome $21$, typically $r(14;21)$ or $r(21;21)$. The woman in this problem has an $r(13;14)$ translocation, which does not involve chromosome $21$. The problem explicitly states to assume the risk contributed by this translocation is $0$ and to ignore other rare causes.\nTherefore, the probability is $0$.\n$$P(RDS|L) = 0$$\nExpressed to four significant figures, the probability is $0.0000$.\n\nThe three requested probabilities, rounded to four significant figures, are:\n- Trisomy $21$: $0.005800$\n- Trisomy $13$: $0.009901$\n- Robertsonian Down syndrome: $0.0000$",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.005800 & 0.009901 & 0.0000 \\end{pmatrix}}$$"
        }
    ]
}